Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
ABTAbbott Laboratories Live data
$109.94▼ -0.52 (-0.5%)as of Nov 11, 2026, 6:21 PM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$81.97$132.02
1-Month Range
Month up 7.1%
$100.51$115.51
Daily Price Range
Day down -0.5%
$109.00$110.33
Volume
vs 10M avg
2M10M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$190.3B
Short % of Float—
Employees—
Sales—
Shares Outstanding1,731,307,986
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.abbott.com
Abbott Laboratories — is a public issuer in the Vantage universe..
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for ABT.
Price targets unavailable — no 12-month targets on file for ABT.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on ABT, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:21 PM UTC